We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Virus Caused Deaths of Transplant Recipients

By HospiMedica staff writers
Posted on 10 May 2007
A new virus was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia. More...
Knowledge of genetic sequence of the virus will enable improvements in screening to enhance transplantation safety.

Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health (New York, NY, USA) and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne (Australia) and 454 Life Sciences (Branford, CT, USA) have discovered a new virus that was responsible for the deaths of transplant recipients.

The previously unknown virus, which is related to lymphocytic choreomeningitis virus (LCMV), was found using rapid sequencing technology established by 454 Life Sciences and bioinformatics algorithms developed in the Greene Laboratory with support from the US National Institute of Allergy and Infectious Diseases. Known strains of LCMV have been implicated in a small number of cases of disease transmission by organ transplantation, however, the newly discovered virus is sufficiently different that it could not be detected using existing screening methods.

Over 30,000 organ transplants are performed in the United States each year. Knowledge of the genetic sequence of this virus will enable improvements in screening that will enhance the safety of transplantation.

Ian Lipkin, M.D., director of the Greene Laboratory and lead investigator of the Northeast Biodefense Center, emphasized the importance of academic, public health, and industrial partnership in this work. This was a team effort. Drs. Mike Catton and Julian Druce at the Victorian Infectious Disease Reference Laboratory reached out to us after a comprehensive state-of-the-art investigation failed to turn up leads, stated Dr. Lipkin. We succeeded in identifying the virus responsible for the deaths by building on their work and utilizing new tools for pathogen surveillance and discovery developed in the Greene Laboratory and 454 Life Sciences.


Related Links:
454 Life Sciences
Greene Infectious Disease Laboratory
Victorian Infectious Diseases Reference Laboratory

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.